Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist
P. K. Um, M. Praharaj, K. A. Lombardo…·T. J. Bivalacqua
This study evaluates a recombinant BCG strain that releases a STING agonist, showing improved antitumor efficacy in bladder cancer models compared to wild-type BCG.